跳至主要内容
临床试验/NCT01750970
NCT01750970已完成不适用

Endoscopic Resection of High Grade(TA, T1, Cis)Non-muscle Invasive Bladder Tumors: Modification of Usual Management of This Resection by Using the Blue Light and Evaluation of the Outcome: Should we Maintain the Dogma of Second Endoscopic Resection as a Principle?

Hopital Foch1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2009年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Hopital Foch
入组人数
68
试验地点
1
主要终点
Number of extra lesions revealed by blue light compared to the resection performed in white light

研究概览

简要总结

To confirm the benefit of endoscopic resection under fluorescence and blue light of high grade non-muscle invasive bladder tumor, and verifying if the second endoscopic resection recommended nowadays can be deleted.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 year-old and older male and female subjects having high grade non-muscle invasive bladder tumor, with urinary cytology , imaging examination (Ultrasound, urography, or scan) and endoscopic examination

排除标准

  • •Less than 18 years of age, and having no:
  • •Non-muscle invasive tumor, and of low grade.
  • •Bladder tumor infiltrating the muscular layer shown by pre-operative test, with absence of urinary cytology
  • •No blue light source in sustainable way

研究组 & 干预措施

Resection under blue light

Experimental

干预措施: Endoscopic resection under blue light (Hexvix®) (Other)

Resection under white light

Active Comparator

干预措施: Endoscopic resection under blue light (Hexvix®) (Other)

结局指标

主要结局

Number of extra lesions revealed by blue light compared to the resection performed in white light

时间窗: 2 to 6 weeks after resection

次要结局

未报告次要终点

研究者

发起方
Hopital Foch
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验